Michael Powell
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Powell
Earlier roles on record: Board Member at Galera Therapeutics, Inc. (GRTXD) until December 30, 2024. Galera Therapeutics, Inc. reported in an 8-K filed December 31, 2024 that Michael Powell resigned as Class I director, effective December 30, 2024.
“In accordance with the Merger Agreement, on December 30, 2024, Michael Powell, Ph.D. (Class I director), Linda West (Class I director) and Emmett Cunningham, M.D., Ph.D. (Class III director) resigned from the Board (collectively, the "Resignations"), effective immediately after the time of the filing of the First Merger Certificate of Merger with the Secretary of State of the State of Delaware (the "First Effective Time").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2016-01-01–2024-12-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.